Organization (Industry)
Fresenius (Germany)
ClinicalTrials.gov lists Fresenius (Germany) as lead sponsor of 105 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Fresenius SE & Co. KGaA, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Fresenius (Germany) and 8 companies grouped under it: 105 lead-sponsored trials (0 its own, 105 in the grouped companies) and 30 legal-entity registrations (1 its own, 29 in the grouped companies).
Companies grouped under this page (8)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Fresenius Kabi (India) | 51 | 7 |
| Fresenius Medical Care Deutschland GmbH | 36 | 1 |
| Fresenius Medical Care North America (United States) | 15 | 1 |
| NxStage Medical, Inc. | 3 | 2 |
| FRESENIUS MEDICAL CARE RENAL SERVICES (SS) LIMITED | 0 | 4 |
Showing 5 of 8 member companies.
Disease areas (14)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Renal Insufficiency, Chronic | 3 |
| Inflammation | 2 |
| Acute Kidney Injury | 1 |
| Cholestasis | 1 |
| Chondrocalcinosis | 1 |
Showing 5 of 14 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2019 | 1 |
| 2016 | 2 |
| 2011 | 1 |
| 2006 | 1 |
| 2005 | 2 |
| 2004 | 1 |
| 2003 | 1 |
| 2002 | 1 |
Showing 10 of 11 years.
Journals published in (18)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 4 |
| Critical care medicine | 3 |
| Transplant international : official journal of the European Society for Organ Transplantation | 3 |
| Transplantation | 3 |
| Transplantation proceedings | 3 |
Showing 5 of 18 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 171 | 0 | 2006-07-04 |
Organization relationships (6)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| University of Milano-Bicocca | Co sponsors trial with | 1 |
| Medac (Germany) | Co sponsors trial with | 1 |
| CONKO-Studiengruppe | Co sponsors trial with | 1 |
| Franco Locatelli | Co sponsors trial with | 1 |
| Universitaire Ziekenhuizen KU Leuven | Co sponsors trial with | 1 |
Showing 5 of 6 relationships.
Latest dated events (184)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-04 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-01-28 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2019-09-17 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2016-11-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2016-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 184 events.
Biomarker capability evidence (14)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CD34 | Trial collaborator | Named in trial inclusion criteria |
| HPN | Trial collaborator | Named in trial inclusion criteria |
| IL1RN | Trial collaborator | Named in trial inclusion criteria |
| TNC | Trial collaborator | Named in trial inclusion criteria |
| IL6 | Trial collaborator | Named in trial exclusion criteria |
Showing 5 of 14 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.